Sterling Pharma Solutions

Sterling Pharma Solutions is a global, full-service CDMO with over 50 years of heritage, providing API and ADC development and manufacturing services to pharmaceutical and biotech clients. The company operates an integrated network of facilities across the UK, Ireland, and the US, offering specialized expertise in complex chemistry, high-potency compounds, and bioconjugation. Its business model is built on providing end-to-end technical support, accelerating clients' molecules from discovery through to commercial launch, with a strong emphasis on scientific innovation, quality, and regulatory compliance.

Specialized API development (high-potency, hazardous chemistry, peptides, flow chemistry, biocatalysis) and ADC bioconjugation services.

Operates in a crowded and competitive global CDMO market. Competes with large, diversified players (e.g., Lonza, Catalent) and other specialized API/ADC manufacturers. Its differentiation lies in its deep expertise in complex chemistry, high-potency handling, and a dedicated ADC bioconjugation facility.